These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26386744)

  • 21. Successfully treated but not fit for purpose: paying attention to chronic lung impairment after TB treatment.
    Harries AD; Ade S; Burney P; Hoa NB; Schluger NW; Castro JL
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1010-4. PubMed ID: 27393532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled corticosteroid is associated with an increased risk of TB in patients with COPD.
    Kim JH; Park JS; Kim KH; Jeong HC; Kim EK; Lee JH
    Chest; 2013 Apr; 143(4):1018-1024. PubMed ID: 23079688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convergence in the Epidemiology and Pathogenesis of COPD and Pneumonia.
    Gautam SS; O'Toole RF
    COPD; 2016 Dec; 13(6):790-798. PubMed ID: 27310416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.
    van Zyl Smit RN; Pai M; Yew WW; Leung CC; Zumla A; Bateman ED; Dheda K
    Eur Respir J; 2010 Jan; 35(1):27-33. PubMed ID: 20044459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification.
    Malhotra R; Olsson H
    Expert Rev Respir Med; 2015 Apr; 9(2):153-9. PubMed ID: 25586213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis.
    Sikjær MG; Løkke A; Hilberg O
    Respir Med; 2018 Feb; 135():35-41. PubMed ID: 29414451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic airflow obstruction syndrome due to pulmonary tuberculosis treated with directly observed therapy--a serious changes in lung function.
    Radovic M; Ristic L; Stankovic I; Pejcic T; Rancic M; Ciric Z; Dinic-Radovic V
    Med Arh; 2011; 65(5):265-9. PubMed ID: 22073848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary nocardiosis in patients with COPD: characteristics and prognostic factors.
    Garcia-Bellmunt L; Sibila O; Solanes I; Sanchez-Reus F; Plaza V
    Arch Bronconeumol; 2012 Aug; 48(8):280-5. PubMed ID: 22656187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis.
    David S; Mateus AR; Duarte EL; Albuquerque J; Portugal C; Sancho L; Lavinha J; Gonçalves G
    PLoS One; 2015; 10(11):e0140625. PubMed ID: 26529092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
    Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
    Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS; Ambaram A; Ainslie GM; Bolliger CT; Feldman C; Geffen L; Irusen EM; Joubert J; Lalloo UG; Mabaso TT; Nyamande K; O'Brien J; Otto W; Raine R; Richards G; Smith C; Stickells D; Venter A; Visser S; Wong M;
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel aspects of pathogenesis and regeneration mechanisms in COPD.
    Bagdonas E; Raudoniute J; Bruzauskaite I; Aldonyte R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():995-1013. PubMed ID: 26082624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of host susceptibility and Mycobacterium tuberculosis virulence define gene expression profile in the host.
    Beisiegel M; Mollenkopf HJ; Hahnke K; Koch M; Dietrich I; Reece ST; Kaufmann SH
    Eur J Immunol; 2009 Dec; 39(12):3369-84. PubMed ID: 19795415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice.
    Beamer GL; Flaherty DK; Vesosky B; Turner J
    Clin Vaccine Immunol; 2008 Mar; 15(3):474-83. PubMed ID: 18184822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes.
    Aryal S; Diaz-Guzman E; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1145-54. PubMed ID: 25342899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial microbiome of lungs in COPD.
    Sze MA; Hogg JC; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2014; 9():229-38. PubMed ID: 24591822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of tuberculosis immunology.
    Fox GJ; Menzies D
    Adv Exp Med Biol; 2013; 783():1-32. PubMed ID: 23468101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.